Pharmaceutical

Korro Bio enters merger deal with Frequency Therapeutics

Korro Bio has signed a definitive merger agreement with Frequency Therapeutics to create a genetic medicines firm.

Jul 17, 2023 - 20:00
Korro Bio enters merger deal with Frequency Therapeutics
Korro Bio has signed a definitive merger agreement with Frequency Therapeutics to create a genetic medicines firm.
Read the original article

Tags:

Previous Article

Vivoryon issues updates on its Alzheimer’s therapy programme

Next Article

Lilly to acquire biopharma firm Versanis for $1.9bn

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Dyno and Roche collaborate on neurological gene therapies

Dyno and Roche collaborate on neurological gene therapies

Oct 26, 2024

The U.K. just cleared a drug to prevent breast cancer. U.S. women may not know it’s already an option

The U.K. just cleared a drug to prevent breast cancer. ...

Nov 13, 2023

Pfizer acquires ADC pioneer Seagen for $43bn

Pfizer acquires ADC pioneer Seagen for $43bn

Mar 23, 2023